Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced imaging in laparoscopic HIPEC for colorectal peritoneal carcinomatosis
2014-003932-38Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of indocyanine green in peritoneal carcinomatosis (PC) and colorectal cancer (CRC), sponsored by Amsterdam University Medical Center. Primary endpoints: Tumor detection sensitivity (advanced imaging modalities) and Tumor detection specificity (advanced imaging modalities). Started Mar 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
peritoneal carcinomatosis (PC)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2014-003932-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003932-38.